For: | Lai HC, Lin HJ, Jeng LB, Huang ST. Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(1): 19-35 [PMID: 36684056 DOI: 10.4251/wjgo.v15.i1.19] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i1/19.htm |
Number | Citing Articles |
1 |
Chunhua Rui, Longhuan Piao, Peng Wang. A commentary on ‘Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study’. International Journal of Surgery 2025; 111(1): 1648 doi: 10.1097/JS9.0000000000001223
|
2 |
Amir Ghaffari Jolfayi, Ali Jafari, Fatemeh Rahmani, Nima Taghizadeh, Soha Mohammadi, Niloufar Rasaei. Handbook of Cancer and Immunology. 2024; : 1 doi: 10.1007/978-3-030-80962-1_417-1
|
3 |
Ankit Jain, Ashwini Kumar Mishra, Pooja Hurkat, Satish Shilpi, Nishi Mody, Sanjay Kumar Jain. Navigating liver cancer: Precision targeting for enhanced treatment outcomes. Drug Delivery and Translational Research 2025; doi: 10.1007/s13346-024-01780-x
|
4 |
Hsiang-Chun Lai, Jui-Chun Weng, Hui-Chi Huang, Jin-Xuan Ho, Chao-Lin Kuo, Ju-Chien Cheng, Sheng-Teng Huang. Solanum torvum induces ferroptosis to suppress hepatocellular carcinoma. Journal of Ethnopharmacology 2024; 335: 118670 doi: 10.1016/j.jep.2024.118670
|